ArticleThe Journal of clinical investigation2021

Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity.

Dayson Moreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.